trial · primary record
INZ-701
Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 13 |
| Primary completion | 2024-12-13 |
| Primary endpoint | Number of Participants With Treatment-Emergent Adverse Events (TEAEs) During the Dose Evaluation Period |
| Registry ID | NCT04686175 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:44.028Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04686175
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.